Intrinsic’s Principals combine over 75 years of investment, healthcare, regulatory and deal structure experience and intend to bring world class operating expertise to build industry leading businesses and brands.
For the last 18 years, Dr. Goodwin has demonstrated a proven acumen investing in healthcare businesses at top investment firms, including Maverick Capital, Citadel Investments and, most recently, as a portfolio manager at Millennium Partners. Dr. Goodwin began his investment career at Graham Partners, a middle-market private equity firm. Prior to beginning his investment career, Dr. Goodwin received his medical degree from Thomas Jefferson University.
Mr. Merlini has 30 years of operational experience and healthcare leadership in biopharmaceuticals, medical devices, consumer health and diagnostics products. Most recently, Mr. Merlini was General Manager for Healthtronics Lab Solutions, the diagnostics division of Endo Pharmaceuticals. Previously, Mr. Merlini ran commercial operations for Core Blood Registry (CBR). Mr. Merlini joined CBR from Johnson & Johnson where he served as Worldwide Vice-President of the Cardiovascular Franchise across Bio-Pharmaceuticals and Commercial Head of the U.S. Nutritionals business.
From January 2010 until December 2017, Mr. Stahlecker served as a top executive at FS Investments, a manager of alternative investment funds focused on private debt and private equity investments. As President of FS Investment Corporation (NYSE: FSIC) and Executive Vice President of FS Investments, Mr. Stahlecker served on the firm’s Executive Committee and on the Investment Committee for each of the firm’s funds, which collectively hold over $20 billion in assets. Mr. Stahlecker oversaw investment management, deal structuring, capital markets, and all finance and legal functions for each of the funds and their respective advisers. Previously, Mr. Stahlecker was a founding partner at Radcliffe Capital Management, a hedge fund management firm, where his responsibilities included serving as Co-Chair of the Investment Committee and Chief Operating Officer for the firm. Earlier in his career, Mr. Stahlecker practiced corporate and securities law, representing venture capital funds, private equity funds, and hedge funds.
Mr. Desmarais is the newest addition to the Intrinsic team, having received his MBA from the MIT Sloan School of Management in June 2019. Prior to receiving his MBA, Mr. Desmarais was an investment associate at Solamere Capital where he performed business, industry and financial diligence. Previously, Mr. Desmarais spent several years at Goldman Sachs where he served as an investment banking analyst, developing detailed financial models and valuation analyses, and conducted industry research for a broad range of corporate finance transactions.